Isoform-specific Regulation of the Coxsackie and Adenovirus Receptor in Polarized Epithelia
极化上皮细胞中柯萨奇和腺病毒受体的亚型特异性调节
基本信息
- 批准号:8879657
- 负责人:
- 金额:$ 44.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-22 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdenovirus InfectionsAdenovirusesAdhesionsAffectAirAlternative SplicingApicalBAIAP1 geneBindingCAR receptorCellsCellular biologyCessation of lifeCoxsackie B VirusesCoxsackie VirusesCoxsackievirus InfectionsDataDegradation PathwayDisease OutbreaksDown-RegulationEndoplasmic ReticulumEnvironmentEpithelialEpithelial CellsEpitheliumExonsFamilyGoalsHealthHumanInfectionInheritedInnovative TherapyKnowledgeLeadLipidsLocationLungLung diseasesMalignant NeoplasmsMediatingMedicineMethodologyMicrobeMilitary PersonnelMolecularMolecular VirologyPathogenesisPathway interactionsPeptidesPredispositionPreventionProductivityProtein IsoformsProteinsQuality ControlRNA SplicingRegulationResearchScaffolding ProteinSideSorting - Cell MovementSterilityStructureSurfaceTechniquesTestingTherapeuticTherapeutic IndexTherapeutic InterventionTight JunctionsTonsilTrainingUniversitiesVaccinationViralViral PathogenesisViral PneumoniaViral VectorVirusVirus DiseasesVirus ReceptorsWorkadenoviral-mediatedadenovirus receptorairway epitheliumapical membranebasebasolateral membraneclinically significantcollegegene therapygene therapy clinical trialglycosylationgraduate studenthuman diseaseimprovedinsightinterstitialmathematical sciencesmembermembrane-associated guanylate kinasemicrobialmimeticsnovelpathogenpreventprotein degradationprotein expressionpublic health relevancereceptorreceptor expressiontraffickingundergraduate studentvirology
项目摘要
DESCRIPTION (provided by applicant): Adenovirus is a common human pathogen that was first identified from tonsils in 1953. Over the past 6 decades, adenovirus research has yielded impressive knowledge about the pathogenesis of viral pneumonias, vaccination, and basic aspects of molecular virology and cellular biology. However, adenovirus remains a significant civilian and military threat since no specific therapeutic treatment for adenoviral infection exist. Adenovirus is also clinically significant because it is the most common viral vector used in human gene therapy clinical trials. New techniques that enhance adenovirus infection would, thus, improve the therapeutic index of these innovative therapies. Most adenoviruses and group B coxsackieviruses share a common receptor: coxsackievirus and adenovirus receptor (CAR). A major unanswered question has been how these pathogenic viruses initiate infection from the air-exposed lung epithelial surface. Our group has recently discovered that one of the two transmembrane isoforms of CAR (CAREx8) can localize at the air-exposed apical epithelial surface. Moreover, we have found that a cellular scaffolding protein, membrane-associated guanylate kinase with inverted domain structure 1 (MAGI-1), serves as a master negative regulator for cellular CAREx8 protein expression levels and apical adenovirus entry. Understanding the mechanism by which MAGI-1 regulates CAREx8 may lead to novel and specific therapeutics able to alter the susceptibility of an epithelium to adenovirus infection. We
hypothesize that MAGI-1 downregulates CAREx8 protein expression by marking CAREx8 as a substrate for the protein-surveillance endoplasmic reticulum associated-degradation (ERAD) pathway. We further hypothesize that molecules that block the MAGI-1-CAREx8 interaction will directly affect the susceptibility of an epithelium to adenovirus infection. We aim to understand the molecular basis of MAGI- 1-mediated CAREx8 down regulation and whether specific cell-permeable peptides can interrupt this interaction to either decrease or increase apical adenovirus infection in polarized epithelia. Understanding these molecular mechanisms is clinically significant for several reasons. Currently there is no specific treatment for coxsackievirus or adenovirus infection; thus, the ability to block virus binding in the face of virl outbreaks would be a significant therapeutic advance. On the other hand, the ability to augment apical expression of the receptor would have high relevance for efficient adenoviral-mediated gene therapy for lung diseases, such as cancer. Finally, this work will expose a team of graduate and undergraduate students to vital research at the interface of virology and medicine.
描述(由申请方提供):腺病毒是一种常见的人类病原体,于1953年首次从扁桃体中发现。在过去的60年里,腺病毒研究已经取得了令人印象深刻的知识,病毒性肺炎的发病机制,疫苗接种,以及分子病毒学和细胞生物学的基本方面。然而,腺病毒仍然是一个重大的民用和军事威胁,因为没有具体的治疗治疗腺病毒感染存在。腺病毒也具有临床意义,因为它是人类基因治疗临床试验中最常见的病毒载体。因此,增强腺病毒感染的新技术将提高这些创新疗法的治疗指数。大多数腺病毒和B组柯萨奇病毒共享一个共同的受体:柯萨奇病毒和腺病毒受体(CAR)。一个主要的未回答的问题是这些致病病毒如何从暴露于空气的肺上皮表面开始感染。我们的小组最近发现CAR的两种跨膜亚型之一(CARex 8)可以定位于暴露于空气的顶端上皮表面。此外,我们已经发现,细胞支架蛋白,膜相关的鸟苷酸激酶与反向结构域结构1(MAGI-1),作为一个主负调节细胞CAREx 8蛋白表达水平和顶端腺病毒进入。了解MAGI-1调节CARex 8的机制可能会导致能够改变上皮对腺病毒感染的易感性的新型和特异性治疗方法。我们
假设MAGI-1通过将CARex 8标记为蛋白质监视内质网相关降解(ERAD)途径的底物来下调CARex 8蛋白表达。我们进一步假设阻断MAGI-1-CARex 8相互作用的分子将直接影响上皮对腺病毒感染的易感性。我们的目的是了解MAGI- 1介导的CARex 8下调的分子基础,以及特定的细胞渗透性肽是否可以中断这种相互作用,以减少或增加极化上皮中的顶端腺病毒感染。了解这些分子机制具有临床意义,原因有几个。目前还没有针对柯萨奇病毒或腺病毒感染的特异性治疗方法;因此,在病毒爆发时阻断病毒结合的能力将是一个重大的治疗进展。另一方面,增强受体顶端表达的能力与有效的腺病毒介导的肺部疾病如癌症的基因治疗具有高度相关性。最后,这项工作将使一个研究生和本科生团队在病毒学和医学的界面上进行重要的研究。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The PDZ3 domain of the cellular scaffolding protein MAGI-1 interacts with the Coxsackievirus and adenovirus receptor (CAR).
细胞支架蛋白 MAGI-1 的 PDZ3 结构域与柯萨奇病毒和腺病毒受体 (CAR) 相互作用。
- DOI:10.1016/j.biocel.2015.01.012
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Yan,Ran;Sharma,Priyanka;Kolawole,AbimbolaO;Martin,SterlingCT;Readler,JamesM;Kotha,PoornimaLN;Hostetler,HeatherA;Excoffon,KatherineJDA
- 通讯作者:Excoffon,KatherineJDA
Sidestream smoke exposure increases the susceptibility of airway epithelia to adenoviral infection.
横向烟雾暴露增加了气道上皮对腺病毒感染的敏感性。
- DOI:10.1371/journal.pone.0049930
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Sharma P;Kolawole AO;Core SB;Kajon AE;Excoffon KJ
- 通讯作者:Excoffon KJ
1. Alternative splicing of viral receptors: A review of the diverse morphologies and physiologies of adenoviral receptors.
1. 病毒受体的选择性剪接:腺病毒受体不同形态和生理学的综述。
- DOI:
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Excoffon,KatherineJDA;Bowers,JonathanR;Sharma,Priyanka
- 通讯作者:Sharma,Priyanka
Poliovirus Receptor: More than a simple viral receptor.
- DOI:10.1016/j.virusres.2017.09.001
- 发表时间:2017-10-15
- 期刊:
- 影响因子:5
- 作者:Bowers JR;Readler JM;Sharma P;Excoffon KJDA
- 通讯作者:Excoffon KJDA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katherine Julie Excoffon其他文献
Katherine Julie Excoffon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katherine Julie Excoffon', 18)}}的其他基金
Prevention of adenovirus pathogenesis through downregulation of the apical adenovirus receptor
通过下调顶端腺病毒受体预防腺病毒发病机制
- 批准号:
9445681 - 财政年份:2017
- 资助金额:
$ 44.4万 - 项目类别:
Molecular evolution of AAV vectors for anti-HIV gene therapy
用于抗 HIV 基因治疗的 AAV 载体的分子进化
- 批准号:
8210652 - 财政年份:2011
- 资助金额:
$ 44.4万 - 项目类别:
Molecular evolution of AAV vectors for anti-HIV gene therapy
用于抗 HIV 基因治疗的 AAV 载体的分子进化
- 批准号:
8294530 - 财政年份:2011
- 资助金额:
$ 44.4万 - 项目类别:
Isoform-Specific Regulation and Localization of the Coxsackie and Adenovirus Rece
柯萨奇病毒和腺病毒 Rece 的异构体特异性调控和定位
- 批准号:
7981132 - 财政年份:2010
- 资助金额:
$ 44.4万 - 项目类别:
相似海外基金
RNA interference based therapies for treatment of adenovirus infections in immunosuppressed host
基于 RNA 干扰的疗法用于治疗免疫抑制宿主的腺病毒感染
- 批准号:
211658021 - 财政年份:2012
- 资助金额:
$ 44.4万 - 项目类别:
Research Grants
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7716731 - 财政年份:2008
- 资助金额:
$ 44.4万 - 项目类别:
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7982151 - 财政年份:2008
- 资助金额:
$ 44.4万 - 项目类别:
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7603956 - 财政年份:2006
- 资助金额:
$ 44.4万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
干细胞移植受体中腺病毒感染的免疫治疗
- 批准号:
7337161 - 财政年份:2006
- 资助金额:
$ 44.4万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplant Recipients
干细胞移植受者腺病毒感染的免疫治疗
- 批准号:
7167150 - 财政年份:2006
- 资助金额:
$ 44.4万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
干细胞移植受体中腺病毒感染的免疫治疗
- 批准号:
7020895 - 财政年份:2006
- 资助金额:
$ 44.4万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
干细胞移植受体中腺病毒感染的免疫治疗
- 批准号:
7545814 - 财政年份:2006
- 资助金额:
$ 44.4万 - 项目类别:
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7368241 - 财政年份:2005
- 资助金额:
$ 44.4万 - 项目类别:
National Surveillance for Emerging Adenovirus Infections
新发腺病毒感染的国家监测
- 批准号:
6899378 - 财政年份:2004
- 资助金额:
$ 44.4万 - 项目类别: